Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Español
English
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
ES
EN
TOC Alert
Volume 2 – Number 2
2025
>
Volume 2 - Number 2
Multidisciplinary perspective on the use of viscoelastic tests in clinical practice (part 1)
2025
>
Volume 2 - Number 2
Factor VIII, IX, and XI measurement by one-stage clotting assay with silica clotting time confirm reagent: a clinical laboratory helpful tool in the presence of lupus anticoagulant
2025
>
Volume 2 - Number 2
About treatment of von Willebrand’s disease in the 21
st
century
2025
>
Volume 2 - Number 2
Editorial
2025
>
Volume 2 - Number 2
Switch from extended half-life factor VIII to emicizumab in a poorly controlled hemophilia A patient: a case report
2025
>
Volume 2 - Number 2
Anti-emicizumab antibodies in severe hemophilia A: report of two cases